Celyad Oncology doses first patient in KEYNOTE-B79 Phase 1b trial
16 December 2021 - 7:51PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Apr 2024 to May 2024
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From May 2023 to May 2024